Prosecution Insights
Prosecution Insights
87 pending office actions • 52 art units • 83 examiners • 0 of 87 (0%) have an AI response strategy ready • 102 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 87 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 87 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (3%) |
| §103 only | 48 (55%) |
| §102 only | 6 (7%) |
| §112 only | 8 (9%) |
| Double-patenting + other | 2 (2%) |
| No statute on record | 20 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REDDIG, PETER J | 3 | 58.0% | +40.0% |
| TICHY, JENNIFER M.H. | 2 | 65.2% | +33.8% |
| SULLIVAN, STEPHANIE LAUREN | 2 | 60.9% | +38.7% |
| HIBBERT, CATHERINE S | 1 | 59.2% | +48.3% |
| WESTERBERG, NISSA M | 1 | 23.4% | +36.9% |
| JACOB, OOMMEN | 1 | 78.8% | +17.4% |
| AEDER, SEAN E | 1 | 56.9% | +19.6% |
| MIGGINS, MICHAEL C | 1 | 80.7% | +16.5% |
| JUEDES, AMY E | 1 | 44.5% | +41.0% |
| DUNNING, RYAN S | 1 | 76.2% | +22.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18675268 | Scalable, Printable, Patterned Sheet Of High Mobility Graphene On Flexible Substrates | MIGGINS, MICHAEL C | 70d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17972105 | MACHINE LEARNING SYSTEMS USING ELECTRONIC HEALTH RECORD DATA AND PATIENT-REPORTED OUTCOMES | HANKS, BENJAMIN L | 92d overdue |
| 17617193 | METHODS AND SYSTEMS FOR PARTICLE BASED TREATMENT USING MICRODOSIMETRY TECHNIQUES | DRAPEAU, SIMEON PAUL | 44d overdue |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | WESTERBERG, NISSA M | 18d overdue |
| 17951985 | ANALYSIS OF PLEURAL LINES FOR THE DIAGNOSIS OF LUNG CONDITIONS | OSINSKI, MICHAEL S | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17781945 | NANOPARTICLE COMPOSITIONS AND METHODS OF USE | REDDIG, PETER J | 85d overdue |
| 18148807 | TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR | REDDIG, PETER J | 66d overdue |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | TICHY, JENNIFER M.H. | 52d overdue |
| 18625699 | METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS | JUEDES, AMY E | 29d overdue |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | WESTERBERG, NISSA M | 18d overdue |
| 19051398 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | HIBBERT, CATHERINE S | 3d overdue |
| 17607837 | MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS | SULLIVAN, STEPHANIE LAUREN | 6d |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | TICHY, JENNIFER M.H. | 14d |
| Art Unit | Apps |
|---|---|
| 1631 | 5 |
| 1646 | 5 |
| 1618 | 3 |
| 1642 | 3 |
| 1637 | 3 |
| 3791 | 3 |
| 1635 | 3 |
| 1633 | 3 |
| 1654 | 3 |
| 1643 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19051398 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | HIBBERT, CATHERINE S | 1658 | Other | Non-Final OA | 3d overdue | Pending | Feb 12, 2025 |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | WESTERBERG, NISSA M | 1618 | Other | Non-Final OA | 18d overdue | Pending | Oct 02, 2024 |
| 18720823 | COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY | JACOB, OOMMEN | 3797 | §112 | Non-Final OA | 33d | Pending | Jun 17, 2024 |
| 18718387 | FULLY CANINE ANTI-CANINE PD-1 ANTIBODIES AND USES THEREOF | AEDER, SEAN E | 1642 | §102 | Non-Final OA | 63d | Pending | Jun 10, 2024 |
| 18675268 | Scalable, Printable, Patterned Sheet Of High Mobility Graphene On Flexible Substrates | MIGGINS, MICHAEL C | 1782 | DPOther | Final Rejection | 70d | Pending | May 28, 2024 |
| 18625699 | METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS | JUEDES, AMY E | 1644 | Other | Final Rejection | 29d overdue | Pending | Apr 03, 2024 |
| 18596876 | ELECTRONICALLY CONTROLLED MICROSCALE OPTICAL RESONATOR | DUNNING, RYAN S | 2872 | §103 | Non-Final OA | 28d | Pending | Mar 06, 2024 |
| 18431638 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | PAPCIAK, SHARON M | 1657 | §103 | Non-Final OA | 97d overdue | Pending | Feb 02, 2024 |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | GROOMS, TIFFANY NICOLE | 1637 | Other | Non-Final OA | 15d | Pending | Dec 21, 2023 |
| 18572717 | Visual Determination of Sleep States | HULBERT, AMANDA K | 3792 | §103 | Non-Final OA | 38d overdue | Pending | Dec 20, 2023 |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | EMCH, GREGORY S | 1678 | Other | Non-Final OA | 31d overdue | Pending | Dec 15, 2023 |
| 18570153 | MATERIAL DEPOSITION ONTO AND RECOVERY FROM SURFACES VIA CONTACTLESS, REVERSIBLE DROPLET WETTING/DE-WETTING BY DIELECTRIC CHARGE INJECTION | SUN, CAITLYN MINGYUN | 1795 | §102 | Non-Final OA | 2d overdue | Pending | Dec 14, 2023 |
| 18563707 | MONITORING OF UPPER LIMB MOVEMENTS TO DETECT STROKE | TOTH, KAREN E | 3791 | §103 | Non-Final OA | 38d overdue | Pending | Nov 22, 2023 |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | MOAZZAMI, NAGHMEH NINA | 1652 | §103 | Non-Final OA | 4d overdue | Pending | Nov 10, 2023 |
| 18494872 | SYSTEMS AND METHODS FOR ORTHOGONAL INTRAVENTRICULAR ACCESS | KIM, SUN U | 1777 | §103 | Non-Final OA | 5d | Pending | Oct 26, 2023 |
| 18368130 | Rat models for CMT2A that develop a progressive neuropathy | LEONARD, ARTHUR S | 1631 | Other | Non-Final OA | 37d overdue | Pending | Sep 14, 2023 |
| 18548481 | TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES | LEE, YIE CHIA | 1642 | §103 | Non-Final OA | 71d overdue | Pending | Aug 30, 2023 |
| 18351151 | BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME | HALVORSON, MARK | 1646 | §103 | Final Rejection | 112d overdue | Pending | Jul 12, 2023 |
| 18260786 | COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA | MIANO, JOSEPH PAUL | 1631 | Other | Non-Final OA | 27d | Pending | Jul 09, 2023 |
| 18343840 | DEVICE FOR CARDIAC IMAGING AND EPICARDIAL ABLATION AND METHODS OF USE THEREOF | LANGHALS, RENEE C | 3797 | §103 | Non-Final OA | 119d overdue | Pending | Jun 29, 2023 |
| 18339565 | CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL | REDDIG, PETER J | 1646 | Other | Final Rejection | 55d | Pending | Jun 22, 2023 |
| 18332150 | USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE | CHANDRA, GYAN | 1674 | Other | Non-Final OA | 5d overdue | Pending | Jun 09, 2023 |
| 18255398 | ENGINEERING OF ORGANOID CULTURE FOR ENHANCED ORGANOGENESIS IN A DISH | FISHER, BRITTANY I | 1796 | §103 | Non-Final OA | 60d overdue | Pending | Jun 01, 2023 |
| 18255154 | NOVEL COMPOSITIONS WITH TISSUE-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME | BARRERA, IMMACULADA | 1671 | §103 | Non-Final OA | 86d overdue | Pending | May 31, 2023 |
| 18254893 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME | YU, DAVID TUYANG | 1635 | §103 | Non-Final OA | 15d overdue | Pending | May 30, 2023 |
| 18253919 | PMO-BASED UTROPHIN::LET-7C MIRNA SITE BLOCKING OLIGONUCLEOTIDES (SBOS) FOR TREATING DUCHENNE MUSCULAR DYSTROPHY (DMD) | ALLEN, SARAH ELIZABETH | 1637 | Other | Non-Final OA | 26d | Pending | May 23, 2023 |
| 18309370 | CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE | GRABER, JAMES J | 1631 | Other | Final Rejection | 44d overdue | Pending | Apr 28, 2023 |
| 18250764 | A HUMAN VASCULAR INJURY-ON-A-CHIP MODEL OF HEMOSTASIS | ALABI, OYELEYE A | 1797 | §102 | Non-Final OA | 56d | Pending | Apr 27, 2023 |
| 18304843 | Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias | KELLY, ROBERT M | 1638 | §112 | Non-Final OA | 26d overdue | Pending | Apr 21, 2023 |
| 18302111 | SYSTEMS AND METHODS FOR EX VIVO PERFUSION OF VERTEBRATE TISSUE | KOSAR, AARON J | 1655 | §103 | Non-Final OA | 22d | Pending | Apr 18, 2023 |
| 18297141 | MECHANICAL MESH FIXATION DEVICE AND CURVILINEAR TACK SYSTEM | BACHMAN, LINDSEY MICHELE | 3771 | §112 | Non-Final OA | 73d overdue | Pending | Apr 07, 2023 |
| 18246872 | COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Other | Non-Final OA | 73d overdue | Pending | Mar 28, 2023 |
| 18187131 | Nanocomposite Films And Methods For Producing The Same | REDDY, KARUNA P | 1764 | §103 | Non-Final OA | 28d | Pending | Mar 21, 2023 |
| 18113254 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR AUTOMATICALLY GENERATING COMPARTMENTALIZATION SECURITY POLICIES AND RULE PREFETCHING ACCELERATION FOR TAGGED PROCESSOR ARCHITECTURES | MAYE, AYUB A | 2436 | §103 | Final Rejection | 40d | Pending | Feb 23, 2023 |
| 18042729 | VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | Other | Non-Final OA | 99d overdue | Pending | Feb 23, 2023 |
| 18112763 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MACHINE LEARNING OF MULTIPLE TASKS | MAUNI, HUMAIRA ZAHIN | 2141 | §103 | Final Rejection | 27d | Pending | Feb 22, 2023 |
| 18040971 | RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION | THUESON, HANNA MARIE | 1638 | §103 | Non-Final OA | 74d overdue | Pending | Feb 07, 2023 |
| 18015800 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Final Rejection | 69d | Pending | Jan 12, 2023 |
| 18148807 | TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR | REDDIG, PETER J | 1646 | Other | Non-Final OA | 66d overdue | Pending | Dec 30, 2022 |
| 18002681 | COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM | MEJIAS, SAMANTHA LEE | 1618 | §103 | Final Rejection | 42d | Pending | Dec 21, 2022 |
| 18000644 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | MIKNIS, ZACHARY J | 1658 | §102 | Non-Final OA | 26d | Pending | Dec 02, 2022 |
| 17928170 | Compositions and Methods for Detecting Respiratory Viruses Including Coronaviruses | BAUSCH, SARAE L | 1699 | §102 | Non-Final OA | 3d overdue | Pending | Nov 28, 2022 |
| 18056562 | Polymer Blends Having Improved Ion Conductivity, Devices, and Methods | CULLEN, SEAN P | 1725 | §103 | Non-Final OA | 26d | Pending | Nov 17, 2022 |
| 17998330 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | RIGA, MICHAEL ANGELO | 1634 | §103 | Final Rejection | 34d | Pending | Nov 09, 2022 |
| 17997298 | COMPOSITIONS AND METHODS OF ADAMTS13 CHIMERIC AUTOANTIBODY RECEPTOR CELLS | JOHANSEN, PETER N. | 1644 | DPOther | Non-Final OA | 78d | Pending | Oct 27, 2022 |
| 17997110 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | SPENCER, ANDREA LYNNE MORRIS | 1631 | Other | Non-Final OA | 6d | Pending | Oct 25, 2022 |
| 17972105 | MACHINE LEARNING SYSTEMS USING ELECTRONIC HEALTH RECORD DATA AND PATIENT-REPORTED OUTCOMES | HANKS, BENJAMIN L | 3684 | §101 | Final Rejection | 92d overdue | Pending | Oct 24, 2022 |
| 17995194 | FACTOR B INHIBITORS AND USES THEREOF | DABKOWSKI, ERINNE R | 1654 | §102 | Final Rejection | 93d overdue | Pending | Sep 30, 2022 |
| 17936654 | METHOD OF TREATING OR AMELIORATING CANCERS DRIVEN BY RECEPTOR TYROSINE KINASE FUSION ONCOGENES, AND COMPOSITIONS FOR THE SAME | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | 10d overdue | Pending | Sep 29, 2022 |
| 17951985 | ANALYSIS OF PLEURAL LINES FOR THE DIAGNOSIS OF LUNG CONDITIONS | OSINSKI, MICHAEL S | 2674 | §101 | Non-Final OA | 4d overdue | Pending | Sep 23, 2022 |
| 17906792 | In vivo targeting of CD4+-T cells for mRNA therapeutics | HUYNH, PHUONG N | 1641 | §103 | Non-Final OA | 126d overdue | Pending | Sep 20, 2022 |
| 17905129 | METHODS OF USING A MULTI-ANALYTE APPROACH FOR DIAGNOSIS AND STAGING A DISEASE | HANEY, AMANDA MARIE | 1682 | §112 | Non-Final OA | 77d overdue | Pending | Aug 26, 2022 |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | 52d overdue | Pending | Aug 24, 2022 |
| 17818854 | METHODS OF INCREASING RESPONSE TO CANCER RADIATION THERAPY | GUSTILO, ESTELLA M | 1646 | Other | Non-Final OA | 93d overdue | Pending | Aug 10, 2022 |
| 17885243 | SYSTEM ARCHITECTURES FOR BIG DATA PROCESSING | CAO, DIEM K | 2196 | §103 | Non-Final OA | 85d overdue | Pending | Aug 10, 2022 |
| 17871702 | PROGRAMMABLE ENZYME-ASSISTED SELECTIVE EXPONENTIAL AMPLIFICATION FOR SENSITIVE DETECTION OF RARE MUTANT ALLELES | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | 22d | Pending | Jul 22, 2022 |
| 17786147 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | PERSONS, JENNA L | 1637 | §103 | Final Rejection | 16d overdue | Pending | Jun 16, 2022 |
| 17784645 | High Performance Platform for Combinatorial Genetic Screening | FLINDERS, JEREMY C | 1684 | §103 | Non-Final OA | 35d overdue | Pending | Jun 11, 2022 |
| 17781945 | NANOPARTICLE COMPOSITIONS AND METHODS OF USE | REDDIG, PETER J | 1646 | §103 | Final Rejection | 85d overdue | Pending | Jun 02, 2022 |
| 17748983 | SPYCATCHER AND SPYTAG: UNIVERSAL IMMUNE RECEPTORS FOR T CELLS | RAHMAN, MASUDUR | 1633 | §103 | Non-Final OA | 73d overdue | Pending | May 19, 2022 |
| 17718922 | ENZYMATIC TARGETING CARIOGENIC BACTERIAL-FUNGAL BIOFILM INTERACTION | ROBERTS, LEZAH | 1612 | §103 | Non-Final OA | 41d | Pending | Apr 12, 2022 |
| 17656660 | TERRITORY MAPPING IN PSEUDO-CONTINUOUS ARTERIAL SPIN LABELING | MERRIAM, AARON ROGERS | 3791 | §103 | Final Rejection | 15d | Pending | Mar 28, 2022 |
| 17689867 | Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome | ESSEX, LAURA ANN | 1675 | §103 | Non-Final OA | 100d overdue | Pending | Mar 08, 2022 |
| 17636950 | UROFLOW MONITORING SYSTEM AND METHOD | MUSTANSIR, ABID A | 3791 | §103 | Final Rejection | 34d | Pending | Feb 21, 2022 |
| 17627260 | DEVICES AND METHODS FOR RAPID SCREENING OF DRUGS OF ABUSE AND OTHER ANALYTES | SVEIVEN, MICHAEL CAMERON | 1678 | §103 | Non-Final OA | 51d overdue | Pending | Jan 14, 2022 |
| 17617193 | METHODS AND SYSTEMS FOR PARTICLE BASED TREATMENT USING MICRODOSIMETRY TECHNIQUES | DRAPEAU, SIMEON PAUL | 2188 | §101 | Final Rejection | 44d overdue | Pending | Dec 07, 2021 |
| 17610334 | INSTRINSICALLY LUBRICATING DRUG-LOADED HYDROGELS FOR USE AS PROPHYLACTIC MEDICAL DEVICES | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | 66d overdue | Pending | Nov 10, 2021 |
| 17607837 | MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Non-Final OA | 6d | Pending | Oct 29, 2021 |
| 17504500 | GLP-1R AGONIST REDUCES RETINAL INFLAMMATION AND NEURON DEATH SECONDARY TO OCULAR HYPERTENSION | BRADLEY, CHRISTINA | 1654 | §103 | Final Rejection | 4d overdue | Pending | Oct 18, 2021 |
| 17602949 | Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins | EDGINGTONGIORDANO, FRANCESCA | 1643 | Other | Final Rejection | 37d overdue | Pending | Oct 11, 2021 |
| 17601581 | COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE | BATES, KEENAN ALEXANDER | 1631 | §103 | Non-Final OA | 5d | Pending | Oct 05, 2021 |
| 17435365 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Final Rejection | 27d | Pending | Aug 31, 2021 |
| 17434894 | METHODS FOR TREATING BLADDER AND URETHRA DYSFUNCTION AND DISEASE | LEE, CHIHYI NMN | 1628 | §112 | Final Rejection | 5d | Pending | Aug 30, 2021 |
| 17373485 | NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME | MONTANARI, DAVID A | 1632 | Other | Non-Final OA | 44d overdue | Pending | Jul 12, 2021 |
| 17356146 | IN VIVO DETECTION OF EGFR MUTATION IN GLIOBLASTOMA VIA MRI SIGNATURE CONSISTENT WITH DEEP PERITUMORAL INFILTRATION | SCHULTZHAUS, JANNA NICOLE | 1685 | §103 | Final Rejection | 36d overdue | Pending | Jun 23, 2021 |
| 17291657 | HEALING AND MORPHOGENESIS OF STRUCTURAL METAL FOAMS AND OTHER MATRIX MATERIALS | KEELING, ALEXANDER W | 1795 | §103 | Non-Final OA | 20d | Pending | May 06, 2021 |
| 17189970 | MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS | MIDDLETON, DANAYA L | 1674 | §112 | Non-Final OA | 18d overdue | Pending | Mar 02, 2021 |
| 17095370 | MEDICAL DEVICE FOR THE PREVENTION OF THROMBOSIS | LEDERER, SARAH B | 3785 | §103 | Final Rejection | 49d overdue | Pending | Nov 11, 2020 |
| 17079119 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR TESTING VISUAL FUNCTION USING VIRTUAL MOBILITY TESTS | JORDAN, DANIEL JEFFERY | 2872 | §103 | Final Rejection | 49d overdue | Pending | Oct 23, 2020 |
| 17047993 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR | DUFFY, BRADLEY | 1643 | §112 | Non-Final OA | 29d | Pending | Oct 15, 2020 |
| 16980064 | BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY | KRISHNAN, GANAPATHY | 1693 | §103 | Final Rejection | 28d | Pending | Sep 11, 2020 |
| 16870484 | Compositions And Methods For Imaging Immune Cells | SAMALA, JAGADISHWAR RAO | 1618 | §103 | Final Rejection | 147d overdue | Pending | May 08, 2020 |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | TICHY, JENNIFER M.H. | 1653 | §103 | Non-Final OA | 14d | Pending | Apr 03, 2020 |
| 16435257 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BRISTOL, LYNN ANNE | 1643 | Other | Final Rejection | 132d overdue | Pending | Jun 07, 2019 |
| 16317943 | TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH A KINASE INHIBITOR | LU, CHENG | 1642 | §103 | Final Rejection | 38d overdue | Pending | Jan 15, 2019 |
| 16093758 | COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | MARTINEZ, TARA L | 1654 | Other | Non-Final OA | 16d overdue | Pending | Oct 15, 2018 |
| 15327794 | SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS | POPA, ILEANA | 1633 | §103 | Non-Final OA | 5d overdue | Pending | Jan 20, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial